Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
12.00
+0.25 (2.13%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Y-mAbs Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018
Market Capitalization
5272972137072,0061,242
Upgrade
Market Cap Growth
-39.61%-69.88%-64.73%61.56%78.51%
Upgrade
Enterprise Value
4522201095301,8951,037
Upgrade
PE Ratio
-32.85-13.88-2.23-12.80-16.81-15.32
Upgrade
PS Ratio
6.233.513.2720.2796.67-
Upgrade
PB Ratio
5.312.951.953.9318.956.24
Upgrade
P/FCF Ratio
-40.48-10.92-2.81-17.17-21.94-16.45
Upgrade
P/OCF Ratio
-40.48-10.92-2.81-6.90-21.99-16.89
Upgrade
EV/Sales Ratio
5.352.601.6715.1791.33-
Upgrade
EV/EBITDA Ratio
-26.15-8.83-1.16-10.06-15.85-12.51
Upgrade
EV/EBIT Ratio
-25.41-8.58-1.15-9.91-15.80-12.49
Upgrade
EV/FCF Ratio
-36.24-8.09-1.44-12.85-20.73-13.74
Upgrade
Debt / Equity Ratio
0.010.010.020.020.040.01
Upgrade
Debt / EBITDA Ratio
-0.05-0.06-0.02-0.07-0.03-0.03
Upgrade
Debt / FCF Ratio
-0.07-0.05-0.02-0.09-0.04-0.03
Upgrade
Quick Ratio
5.475.024.186.795.8715.25
Upgrade
Current Ratio
6.155.524.617.266.2615.60
Upgrade
Asset Turnover
0.660.640.410.140.130
Upgrade
Interest Coverage
---125.25-28.85--
Upgrade
Return on Equity (ROE)
-21.40%-20.70%-75.50%-25.20%-87.80%-62.50%
Upgrade
Return on Assets (ROA)
-16.90%-16.30%-59.60%-22.40%-75.00%-55.30%
Upgrade
Return on Capital (ROIC)
-24.99%-25.07%-85.42%-62.82%-109.22%-41.27%
Upgrade
Earnings Yield
-4.11%-7.20%-44.85%-7.81%-5.95%-6.53%
Upgrade
FCF Yield
-3.34%-9.15%-35.63%-5.83%-4.56%-6.08%
Upgrade
Buyback Yield / Dilution
-0.25%0.13%-1.21%-7.64%-14.03%-22.28%
Upgrade
Total Shareholder Return
-0.25%0.13%-1.21%-7.64%-14.03%-22.28%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).